FdaApplication
NDA 219428
Identifiers
- fda_app_no: NDA219428
Properties
| Property | Value |
|---|---|
| applicant_name | TONIX PHARMACEUTICALS INC |
| application_type | NDA |
| approval_date | 2025-08-15 |
Revenue by product
TONMYA
| Period | Revenue |
|---|---|
| Q2 2026 | $11.0M |
| Q1 2026 | $3.7M |
Revenue as this company reported it for this product. A combination product's amount is stated once, for the product, and never divided across its ingredients.
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| TONMYA | CYCLOBENZAPRINE HYDROCHLORIDE | 2.8MG | TABLET;SUBLINGUAL |
1 product